Bio-Techne (TECH) insider buying

Healthcare · Biotechnology · Market cap $11.5B

20 open-market purchases of TECH by Bio-Techne's executives and directors since February 2025, worth $0 in total, from SEC Form 4 filings.

The most recent: Ro Khanna bought — on March 30, 2026.

The biggest buyer over the period is Ro Khanna: 8 purchases, $0.

By year

YearPurchasesValue
20264$0
202516$0

Biggest buyers

InsiderBuysValue
Ro Khanna
8$0
April Mcclain Delaney
10$0
Robert Bresnahan, Jr.
2$0

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Mar 30, 2026 Ro Khanna
0$52.04— —
Mar 30, 2026 Ro Khanna
0$52.04— —
Jan 29, 2026 Ro Khanna
0$63.98— —
Jan 29, 2026 Ro Khanna
0$63.98— —
Dec 5, 2025 April Mcclain Delaney
0$61.68— —
Dec 5, 2025 April Mcclain Delaney
0$61.68— —
Dec 2, 2025 April Mcclain Delaney
0$62.95— —
Dec 2, 2025 April Mcclain Delaney
0$62.95— —
Oct 22, 2025 April Mcclain Delaney
0$63.79— —
Oct 22, 2025 April Mcclain Delaney
0$63.79— —
May 28, 2025 Ro Khanna
0$47.93— —
May 28, 2025 Ro Khanna
0$47.93— —
May 19, 2025 Ro Khanna
0$49.28— —
May 19, 2025 Ro Khanna
0$49.28— —
Apr 29, 2025 April Mcclain Delaney
0$50.50— —
Apr 29, 2025 April Mcclain Delaney
0$50.50— —
Apr 9, 2025 April Mcclain Delaney
0$54.07— —
Apr 9, 2025 April Mcclain Delaney
0$54.07— —
Feb 25, 2025 Robert Bresnahan, Jr.
0$64.22— —
Feb 25, 2025 Robert Bresnahan, Jr.
0$64.22— —
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for TECH.
Open TECH in Investingly

Questions

Are Bio-Techne insiders buying the stock?

20 open-market purchases of TECH by Bio-Techne's executives and directors since February 2025, worth $0 in total, from SEC Form 4 filings. The most recent: Ro Khanna bought — on March 30, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Bio-Techne's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.